SCHEMBL10033923

SCHEMBL10033923

Cc1noc(CC(c2ccc(F)cc2)S(=O)(=O)O)c1[N+](=O)[O-]

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.39
HTT P42858 1/20 0.39
MAPT P10636 6/20 0.38
SMN1; SMN2 Q16637 5/20 0.38
NPC1 O15118 4/20 0.38
RAB9A P51151 4/20 0.38
LMNA P02545 2/20 0.38
PABPC1 P11940 1/20 0.38
NFKB1 P19838 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.36
EDNRB P24530 2/20 0.35
EDNRA P25101 2/20 0.35
KMT2A Q03164 5/20 0.34
MEN1 O00255 4/20 0.34
BRD4 O60885 1/20 0.33
BCL6 P41182 1/20 0.33
BCOR Q6W2J9 1/20 0.33
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10033921 0.90 ALDH1A1 (0.44) ALDH1A1HTTMAPTSMN1; SMN2NPC1
SCHEMBL10033924 0.89 GPX4 (0.40) ALDH1A1HTTMAPTSMN1; SMN2NPC1
SCHEMBL10033894 0.88 KMT2A (0.39) ALDH1A1HTTMAPTSMN1; SMN2NPC1
SCHEMBL10033926 0.87 KMT2A (0.37) ALDH1A1HTTMAPTSMN1; SMN2NPC1
SCHEMBL10033922 0.87 GAA (0.41) ALDH1A1HTTMAPTSMN1; SMN2NPC1
SCHEMBL522589 0.73 ALDH1A1 (0.47) ALDH1A1HTTMAPTSMN1; SMN2NPC1
SCHEMBL14976523 0.71 MAPT (0.34) ALDH1A1HTTMAPTSMN1; SMN2NPC1
SCHEMBL14986110 0.70 MEN1 (0.35) ALDH1A1HTTMAPTSMN1; SMN2NPC1
SCHEMBL16232504 0.67 MEN1 (0.33) ALDH1A1MAPTSMN1; SMN2NPC1RAB9A
SCHEMBL14976615 0.66 KMT2A (0.33) ALDH1A1HTTMAPTSMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120029197-A1 Method for Preparing Sulfur-Containing Compounds THE ROYAL COLLEGE OF SURGEONS IN IRELAND (IE) 2012-02-02 US disclosed
US-20120029197-A1 Method for Preparing Sulfur-Containing Compounds THE ROYAL COLLEGE OF SURGEONS IN IRELAND (IE) 2012-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120029197-A1 Method for Preparing Sulfur-Containing Compounds SULT1E1, SULT1A1, TST ALDH1A1 195/4885HTT 3916/4885MAPT 4581/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.